Retatrutide 40mg Alluvi Healthcare

Alluvi Retatrutide 40mg is an injectable peptide formulated as a triple agonist of GLP-1, GIP, and glucagon receptors, currently studied for its potential role in weight management and metabolic health.

Potential Positive

• May help reduce appetite and support weight loss
• Supports metabolic and energy balance pathways
• May improve blood sugar regulation and insulin sensitivity
• Advanced multi-receptor action compared to single GLP-1 options